Saint Paul, MN, United States of America

John Scandurra

USPTO Granted Patents = 22 

 

Average Co-Inventor Count = 2.4

ph-index = 9

Forward Citations = 248(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
22 patents (USPTO):Explore Patents

Title: Innovations by John Scandurra in Pulmonary Health

Introduction

John Scandurra, based in Saint Paul, MN, has made significant contributions to medical technology, particularly in the field of cardiology. With an impressive portfolio of 21 patents, Scandurra focuses on developing systems and methods that address critical health issues such as pulmonary hypertension and heart disease.

Latest Patents

Among his latest innovations is a system for treating pulmonary hypertension, which combines an implantable component with external monitoring tools. This system includes a compliant member, such as a balloon, which is designed to be placed in a pulmonary artery, linked to a subcutaneously implanted reservoir. The external components encompass a clinical controller and monitoring software that enables healthcare professionals to oversee patient conditions and treatments via a mobile application.

Another notable invention is a device aimed at reducing pulsatile pressure within a lumen. This device consists of a fluid reservoir, an injection port, a compliant body that adjusts to pressure variations, and a conduit connecting the two. This invention is designed to utilize either a compressible or noncompressible fluid, delivering innovative solutions for managing internal pressures.

Career Highlights

John Scandurra has been associated with Aria CV, Inc. and the University of Minnesota, where he has developed and expanded his groundbreaking inventions. His work has significantly impacted the field of medicine, particularly in enhancing treatment options for patients suffering from heart diseases.

Collaborations

Throughout his career, Scandurra has collaborated with esteemed professionals including Karl Vollmers and Christopher Scorzelli. These collaborations have likely played a crucial role in refining his inventions and implementing them effectively in clinical settings.

Conclusion

John Scandurra stands out as a notable inventor in the medical technology industry, particularly with his innovative approaches to treating pulmonary hypertension and heart disease. His extensive patent portfolio reflects his commitment to improving patient care and advancing medical science. As he continues to develop new solutions, Scandurra is poised to make an even greater impact on the healthcare landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…